Market Overview:
The global nasal delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of allergic and non-allergic rhinitis, nose congestion, and other therapeutic applications. In addition, the growing demand for vaccines is also contributing to the growth of this market. The global nasal delivery market can be segmented on the basis of type into sprays, drops & liquids, powders, and gels. The sprays segment is expected to dominate this market during the forecast period owing to their ease of use and high efficacy rates. On the basis of application, this market can be divided into allergic and non-allergic rhinitis, nose congestion reliefs (including colds), vaccination (paediatric/adult), and other therapeutic applications such as sinus infections or pain reliefs etc.). Allergic rhinitis currently dominates this application segment due its high prevalence rate across all regions studied in this research study.
Product Definition:
The term nasal delivery refers to the use of the nose and nasal passages as a conduit for medicines, vaccines, or other therapeutic agents. The importance of nasal delivery is that it can help to improve drug absorption and distribution. This is particularly important for drugs that are delivered locally to the nose, such as decongestants and antihistamines.
Sprays:
Sprays are a convenient and non-invasive method of delivering medications to the nose. They can be used for treating colds, allergies, runny nose, congestion due to cold or flu. Sprays are also useful in treating sneezing and itchy eyes due to various conditions like hay fever or asthma.
The nasal route offers several advantages over oral medications including quick absorption with minimal gastrointestinal side effects; therefore many patients prefer sprays over tablets or capsules.
Drops & Liquids:
Nasal drops and liquids are solutions of drugs that are administered in the nose. The drug is absorbed by the nose tissues directly and then transported to the brain. This mode of drug delivery allows for a more rapid onset of action, which may be beneficial for some patients who have acute pain or need rapid relief from pain.
Application Insights:
The other therapeutic applications segment held the largest market share of over 40% in 2017. This is attributed to the rising number of patients suffering from various diseases such as asthma, nasal congestion and allergic rhinitis. Nasal sprays, drops and gels are considered to be among the most popular forms of these drugs due to their ease in application as well as removal. Moreover, owing to their quick-acting nature, they are highly preferred among patients seeking treatment for a variety of disorders pertaining to the nose or its surrounding areas.
The vaccination segment is expected register considerable growth during forecast years due largely declining disease incidence rates coupled with increasing government initiatives towards immunization against a wide range of illnesses including chickenpox & measles throughout all regions globally. The aforementioned factors have led toward an increased demand for nasal delivery systems that assist in delivering vaccines directly into each nostril without having them fall out or get stuck inside (blockage).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about nasal delivery systems and rising healthcare expenditure. In addition, growing number of product launches and favorable reimbursement policies are also contributing towards regional growth. For instance, in June 2018, Netter launched a new line of drops for nasal congestion under the brand name ‘Nasalcort’in U.S., which is indicated for allergic rhinitis treatment as well as prevention of future attacks (preventive use).
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure & affordability in emerging markets such as China & India. Moreover, increasing focus on novel drug development by major players will drive regional growth further due to rise in investment by companies such as Allergan Plc., Actavis Plc., Pfizer Inc.
Growth Factors:
- Increasing incidence of respiratory diseases: The global incidence of respiratory diseases is increasing rapidly. This is primarily because of the changing lifestyle and environmental conditions. Respiratory diseases are caused by viruses, bacteria, or other organisms that affect the lungs and airways. They can be acute or chronic in nature and can cause a wide range of symptoms such as coughing, wheezing, chest pain, shortness of breath etc. The most common respiratory diseases include pneumonia, bronchitis, asthma etc.
- Growing awareness about the benefits of nasal delivery: There is a growing awareness among people about the benefits of using nasal delivery devices for medications and other treatments. Nasal delivery offers several advantages over traditional oral delivery methods such as faster absorption into the bloodstream, better patient compliance due to ease-of-use etc. This is driving demand for nasal delivery devices and products worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nasal Delivery Market Research Report
By Type
Sprays, Drops & Liquids, Powders, Gels
By Application
Allergic And Non-allergic Rhinitis, Nose Congestion, Vaccination, Other Therapeutic Applications
By Companies
Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., 3M, Becton, Dickinson and Company, Aegis Therapeutics LLC, Aptargroup, Inc., Astrazeneca
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Nasal Delivery Market Report Segments:
The global Nasal Delivery market is segmented on the basis of:
Types
Sprays, Drops & Liquids, Powders, Gels
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergic And Non-allergic Rhinitis, Nose Congestion, Vaccination, Other Therapeutic Applications
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co., Inc.
- Novartis AG
- Glaxosmithkline PLC
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- 3M
- Becton, Dickinson and Company
- Aegis Therapeutics LLC
- Aptargroup, Inc.
- Astrazeneca
Highlights of The Nasal Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sprays
- Drops & Liquids
- Powders
- Gels
- By Application:
- Allergic And Non-allergic Rhinitis
- Nose Congestion
- Vaccination
- Other Therapeutic Applications
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nasal Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nasal delivery is a method of delivering medications, supplements, and other treatments directly into the nose. This approach can be more effective than traditional methods such as swallowing or injecting because it bypasses the digestive system. Nasal delivery also allows for repeated doses to be delivered over time without having to take multiple pills or injections each time.
Some of the major companies in the nasal delivery market are Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., 3M, Becton, Dickinson and Company, Aegis Therapeutics LLC, Aptargroup, Inc., Astrazeneca.
The nasal delivery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nasal Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nasal Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nasal Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nasal Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nasal Delivery Market Size & Forecast, 2018-2028
4.5.1 Nasal Delivery Market Size and Y-o-Y Growth
4.5.2 Nasal Delivery Market Absolute $ Opportunity
Chapter 5 Global Nasal Delivery Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nasal Delivery Market Size Forecast by Type
5.2.1 Sprays
5.2.2 Drops & Liquids
5.2.3 Powders
5.2.4 Gels
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nasal Delivery Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nasal Delivery Market Size Forecast by Applications
6.2.1 Allergic And Non-allergic Rhinitis
6.2.2 Nose Congestion
6.2.3 Vaccination
6.2.4 Other Therapeutic Applications
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nasal Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nasal Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nasal Delivery Analysis and Forecast
9.1 Introduction
9.2 North America Nasal Delivery Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nasal Delivery Market Size Forecast by Type
9.6.1 Sprays
9.6.2 Drops & Liquids
9.6.3 Powders
9.6.4 Gels
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nasal Delivery Market Size Forecast by Applications
9.10.1 Allergic And Non-allergic Rhinitis
9.10.2 Nose Congestion
9.10.3 Vaccination
9.10.4 Other Therapeutic Applications
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nasal Delivery Analysis and Forecast
10.1 Introduction
10.2 Europe Nasal Delivery Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nasal Delivery Market Size Forecast by Type
10.6.1 Sprays
10.6.2 Drops & Liquids
10.6.3 Powders
10.6.4 Gels
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nasal Delivery Market Size Forecast by Applications
10.10.1 Allergic And Non-allergic Rhinitis
10.10.2 Nose Congestion
10.10.3 Vaccination
10.10.4 Other Therapeutic Applications
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nasal Delivery Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nasal Delivery Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nasal Delivery Market Size Forecast by Type
11.6.1 Sprays
11.6.2 Drops & Liquids
11.6.3 Powders
11.6.4 Gels
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nasal Delivery Market Size Forecast by Applications
11.10.1 Allergic And Non-allergic Rhinitis
11.10.2 Nose Congestion
11.10.3 Vaccination
11.10.4 Other Therapeutic Applications
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nasal Delivery Analysis and Forecast
12.1 Introduction
12.2 Latin America Nasal Delivery Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nasal Delivery Market Size Forecast by Type
12.6.1 Sprays
12.6.2 Drops & Liquids
12.6.3 Powders
12.6.4 Gels
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nasal Delivery Market Size Forecast by Applications
12.10.1 Allergic And Non-allergic Rhinitis
12.10.2 Nose Congestion
12.10.3 Vaccination
12.10.4 Other Therapeutic Applications
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nasal Delivery Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nasal Delivery Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nasal Delivery Market Size Forecast by Type
13.6.1 Sprays
13.6.2 Drops & Liquids
13.6.3 Powders
13.6.4 Gels
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nasal Delivery Market Size Forecast by Applications
13.10.1 Allergic And Non-allergic Rhinitis
13.10.2 Nose Congestion
13.10.3 Vaccination
13.10.4 Other Therapeutic Applications
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nasal Delivery Market: Competitive Dashboard
14.2 Global Nasal Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co., Inc.
14.3.2 Novartis AG
14.3.3 Glaxosmithkline PLC
14.3.4 Johnson & Johnson Services, Inc.
14.3.5 Pfizer Inc.
14.3.6 3M
14.3.7 Becton, Dickinson and Company
14.3.8 Aegis Therapeutics LLC
14.3.9 Aptargroup, Inc.
14.3.10 Astrazeneca
